 Home > Medical News >

Medical Research Articles

FDA approves Jansen Pharmaceuticals STELARA ® (ustekinumab) for treatment of adult patients with ulcerative colitis

 Time of Update: 2020-06-07

fda approved vitamin candesartan 8 mg design 6 rev 6 8 imuran ulcerative colitis

today, Johnson and Johnson's Janssen Pharmaceutical (http:// announced that its product (http:// STELARA ® (usinumab) has been approved by the FDA (http:// for the treatment of adult patien
FDA approves AstraZeneca Farxiga new indications

 Time of Update: 2020-06-07

ozempic weight loss terlipressin fda approval hangover blood pressure phentermine fda approved turmeric blood sugar

recently, AstraZeneca announced The FDA (http:// approvefariga's new indications to reduce the risk of hospitalization for heart failure in patients with type 2 diabetes with cardiovascular disea
China's National Drug Administration approves PARP inhibitor Lynparza for treatment of patients with advanced ovarian cancer

 Time of Update: 2020-06-07

study cancer pd 1 therapy makeup cancer patients platinum therapy lights 1 support

recently, AstraZeneca and Mersadong jointly announced that China's National Medicines (http:// Regulatory Authority has officially approved its PARP inhibitor Lynparza (Olapari) for the first-lin
China's State Drug Administration approves clinical trial application for Skyland Bio TJM2

 Time of Update: 2020-06-07

flecainide drug interactions ecasa drug china pharmaceutical university natural products near calcitonin drug

Recently, Tianyuan Biotech (Shanghai) Limited Company (http:// ("Tianyuan Bio") announced that China's National Pharmaceutical (http:// Regulatory Authority has approved the tJM2 Clinical Tes
FDA approves Reblozyl (luspatercept-aamt) for treatment of adult patients with thalassemia

 Time of Update: 2020-06-07

phase 5 band ambien active ingredient cell gene therapy abilify drug class contact dependent signaling

recently, The u.S Food and Drug (http:// Authority ( ) of the Food and Medicines http:// ( ) has approved Reblozyl (luspatercept-aamt) for adult patients with beta-thalassemia who require reg
FDA grants Astellas ASP1128 fast-track eligibility

 Time of Update: 2020-06-07

adc drug truvada drug zytiga drug sinemet drug motrin drug

recently, Japanese drug maker Astellas announced that the U.S Food and Drug (http:// Administration ( FDA (http:// ) has granted ASP11128 fast-track eligibility for the treatment of patients wit
Deciphera Inc. submits new drug application to FDA

 Time of Update: 2020-06-07

1 3 diene 1 alpha 15 2 simplified 1 4 socket ehrlich test kit

today, Deciphera (http:// announced that it has submitted its kit and PDGFR alpha kinase inhibitor ripretinib's new drug (http:// application (NDA) to the U.S FDA (http:// for the treatment
TMC announces detailed data from clinical study of siRNA lipid-lowering drug inclisiran III

 Time of Update: 2020-06-07

cardura 4 mg 1 2 dimethoxybenzene ropinirole 0.5 mg 3 2 simplified vraylar 3 mg

recently, (http:// a company at TMC, released detailed data on the siRNA fat-lowering drug (http:// inclisiran III clinical study ORION-10 This is the second of three key Phase III clinical s
FDA accepts biota license application for gene tekil-6 antibody satralizumab

 Time of Update: 2020-06-07

risk 7 1 cm 1 4 cyclohexanedione 1 4 addition 5 3 models

Today, Roche's Genentech announced that the U.S FDA (http:// has accepted its IL-6 antibody satralizumab biologic license application (BLA) for the treatment of adult synods and adolescent patien
FDA approves Alexion's long-acting C5 tonic inhibitor Ultromiris (ravulizumab-cwvz) extended indications

 Time of Update: 2020-06-07

korsakoff syndrome treatment long acting injectables kidney function terlipressin fda approval kidney awareness month

recently, Alexion Pharmaceuticals (http:// announced that the U.S FDA (http:// approved the company's long-acting C5 tonic inhibitor Ultromiris (ravulizumab-cwvz) extended indications for the
Avapritinib obtained excellent clinical data in Phase 2 trials for the treatment of patients with inert systemic hyperplasia

 Time of Update: 2020-06-07

serum protein hpv type 1 data screening thymosin alpha 1 autism clinical trials

recently, Blueprint Medicines (http:// announced that its oral KIT and PDGFR alpha inhibitor avapritinib, obtained excellent preliminary clinical data in the Phase 2 trial (http:// PIONEER for
Phase III clinical trial of TransCon human growth hormone obtains NMPA approval

 Time of Update: 2020-06-07

k2 drug effects computer duster drug excel clinical lab levemir long acting lamictal drug interactions

growth hormone deficiency (GHD) refers to growth retardation caused by growth hormone secretion dysfunction, which is a disease that seriously affects the physical and mental health of children and
FDA grants Mirum selective ASBT inhibitor maralixibat breakthrough therapy

 Time of Update: 2020-06-07

liver disease stages amino acid treatment essential oil itching levels levels protein folding

today, Mirum Pharmaceuticals (http:// announced that the U.S FDA (http:// granted its selective ASBT inhibitor maralixibat breakthrough therapy to treat itching symptoms in children 1 years an
Study reveals mechanisms that increase "abdominal fat" around organs as they get older

 Time of Update: 2020-06-07

new age automotive cells body ph levels body healthy body eosinophil cells work

recently published in the journal Cell me tabolism, researchers from Yale University revealwhy that "abdominal fat" around organs increases as we age The findings could provide new treatment possib
FerGene Gene Therapy Nadofaragene Firadenovec Phase 3 Clinical Trial Reaches Major Clinical End

 Time of Update: 2020-06-07

cr protein p53 gene kill cancer cells ps 12 3 gapdh gene

recently, Genetherapy company (http:// FerGene announced that gene therapy nadofaragene firadenovec (rAd-IFN/Syn3) has reached a major clinical end point in the clinical trial (http:// for pat
FDA approves new oral fumarate drug Vumerity for treatment of recurrent multiple sclerosis

 Time of Update: 2020-06-07

1 4 cyclohexadiene half 1 3 4 2 4 db 3 pi 4 nystagmus multiple sclerosis

today, http:// the u.S FDA (http:// officially approved its new oral fumarate drug (http:// ) for the treatment of recurrent multiple sclerosis (MS) patients, announced Vumerity is a prec
Poxel SA's oral type 2 diabetes innovative therapy imeglimin Phase 3 clinical trial gets positive top-line results

 Time of Update: 2020-06-07

liraglutide mechanism action 1 3 butanediol liver regeneration time imeglimin forteo mechanism action

today, Poxel SA company (http:// announced that the company's innovative oral type 2 diabetes treatment, imeglimin, has achieved positive top-line results in the Open Label Extension Research sec
Baiji State BRUKINSA ™ (Zebutini) gets accelerated FDA approval

 Time of Update: 2020-06-07

blood test tube ceruloplasmin blood test urinary tract health ice phase diagram small cell lymphoma

Today, Baiji Shenzhou announced that the BRUKINSA ™ (BRUKINSA ™, General Name: Zebutini) has been approved by the U.S Food Drug (http:// Regulatory Authority ( FDA (http:// ) to accelerate appro
FDA Grants Kochi E. Bio053 Regenerative Medicine Advanced Therapy Qualifications

 Time of Update: 2020-06-07

9 10 diphenylanthracene american bio hospital bacteria fda drug classification hospital waste

today, Cozie Bio announced that the U.S Food and Drug (http:// Administration ( FDA (http:// ) has granted its (http:// CT053 Regenerative Medicine Advanced Therapy (RMAT) for the treatment
FDA grants F2G candidate drug olorofim breakthrough therapy

 Time of Update: 2020-06-07

senna drug class alcohol dehydrogenase enzyme new synthetic drugs strattera drug class abilify drug class

, F2G (http:// announced that the U.S FDA (http:// awarded its first -candidate drug (http:// olorofim breakthrough therapy for treatment of patients with invasive fungal infections Olorofim

Go to Page

Medical Research Articles

FDA approves Jansen Pharmaceuticals STELARA ® (ustekinumab) for treatment of adult patients with ulcerative colitis

FDA approves AstraZeneca Farxiga new indications

China's National Drug Administration approves PARP inhibitor Lynparza for treatment of patients with advanced ovarian cancer

China's State Drug Administration approves clinical trial application for Skyland Bio TJM2

FDA approves Reblozyl (luspatercept-aamt) for treatment of adult patients with thalassemia

FDA grants Astellas ASP1128 fast-track eligibility

Deciphera Inc. submits new drug application to FDA

TMC announces detailed data from clinical study of siRNA lipid-lowering drug inclisiran III

FDA accepts biota license application for gene tekil-6 antibody satralizumab

FDA approves Alexion's long-acting C5 tonic inhibitor Ultromiris (ravulizumab-cwvz) extended indications

Avapritinib obtained excellent clinical data in Phase 2 trials for the treatment of patients with inert systemic hyperplasia

Phase III clinical trial of TransCon human growth hormone obtains NMPA approval

FDA grants Mirum selective ASBT inhibitor maralixibat breakthrough therapy

Study reveals mechanisms that increase "abdominal fat" around organs as they get older

FerGene Gene Therapy Nadofaragene Firadenovec Phase 3 Clinical Trial Reaches Major Clinical End

FDA approves new oral fumarate drug Vumerity for treatment of recurrent multiple sclerosis

Poxel SA's oral type 2 diabetes innovative therapy imeglimin Phase 3 clinical trial gets positive top-line results

Baiji State BRUKINSA ™ (Zebutini) gets accelerated FDA approval

FDA Grants Kochi E. Bio053 Regenerative Medicine Advanced Therapy Qualifications

FDA grants F2G candidate drug olorofim breakthrough therapy